| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.0M | -22.6% | -22.5% |
| R&D Expense | $854K | -1.8% | +27.7% |
| SG&A Expense | $10.0M | -4.6% | +19.3% |
| Operating Income | -$6.3M | -23.6% | -26.6% |
| Pre-tax Income | -$6.6M | -25.3% | -17.2% |
| Income Tax | $6K | -71.4% | +100.0% |
| Net Income | -$6.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.4M | -52.8% | +18.9% |
| Inventory | $4.3M | +7.5% | -33.7% |
| Current Assets | $14.4M | -23.4% | -14.9% |
| Total Assets | $15.4M | -23.5% | -16.7% |
| Current Liabilities | $12.6M | -36.2% | +13.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.0M | — | — |
| Capital Expenditures | $3K | — | — |
| Investing Cash Flow | -$3K | — | — |
| Financing Cash Flow | $8.5M | — | — |
| Free Cash Flow | -$11.0M | — | — |
| -24.9% |
| -17.3% |
| EPS (Basic) | -$0.62 | -8.8% | +36.7% |
| EPS (Diluted) | -$0.62 | -8.8% | +36.7% |
| $18.0M |
| -27.5% |
| +38.6% |
| Stockholders' Equity | -$2.6M | +44.7% | -146.7% |